Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 5333 record(s)

Req # A-2023-2024-013

I'd like to know the details of the following lobbyist meeting and what was discussed as it happened a few days before this MP met with CBC to discuss journalism and reporting of Israel-Palestine. Monthly Communication Report Return to 12-Month Lobbying Summary - B'nai Brith Committee for Justice in Canada / le comite pour la justice au Canada - B'nai Brith Canada 366772-581032 Organization: B'nai Brith Committee for Justice in Canada/le comite pour la justice au Canada - B'nai Brith Canada Associated registration: 946195-366772-10 Communication date: 2023-10-30 Posted date: 2023-11-03 Designated Public Office Holders who participated in the communication: Lisa Hepfner, Member of Parliament House of Commons Subject Matter of the communication: Media Responsible Officer who filed this communication report: Michael

Organization: Office of the Commissioner of Lobbying of Canada

0 page(s)
March 2024

Req # A-2019-000270

Adverse Drug Reactions (ADRs). Report numbers: 000146129, 000191438, 000335588, 000335771, 000338151, 000345474, 00389283, 000390319, 000593310, E2B_00570261, E2B_00570262, E2B_00570263, E2B_00570264.

Organization: Health Canada

81 page(s)
February 2024

Req # A-2020-000388

Adverse Drug Reactions (ADRs). Report numbers: E2B_02731350, E2B_02777680, E2B_02810755, E2B_02838946, E2B_02852030, E2B_02856401, E2B_02777244, 000735201, E2B_02869967, E2B_02869987, E2B_02869946, E2B_02871897, E2B_02871900, E2B_02871882, E2B_02871883.

Organization: Health Canada

185 page(s)
February 2024

Req # A-2020-000647

Adverse Drug Reactions (ADRs) for PANTOPRAZOLE. Report numbers: 000736259, 000738096, 000911912, E2B_02993730, E2B_03001785, E2B_03004317, E2B_03005410, E2B_03015111, E2B_03020794, E2B_03024205, E2B_03034122, E2B_03038830, E2B_03047792. ADRs for PANTOPRAZOLE MAGNESIUM. Report numbers: E2B_03047105, E2B_03003181, E2B_03005697, 000908663. ADR for PANTOPRAZOLE SODIUM. Report number: E2B_03045008. ADR for TECTA. Report number: E2B_03014229.

Organization: Health Canada

563 page(s)
February 2024

Req # A-2020-000731

Adverse Drug Reactions (ADRs) for Estrogel. Report numbers: 000693076, E2B_002778333. ADR for Ezetrol. Report number: E2B_01181304. ADRs for Fosamax. Report numbers: 000675450, 00685185, E2B_00037382, 000518360, 000555402, 000543195, E2B_00256053, E2B_00066044.

Organization: Health Canada

221 page(s)
February 2024

Req # A-2020-000800

Adverse Drug Reactions (ADRs) for Fosamax. Report numbers: E2B_00498826, E2B_00498902, E2B_00500827, E2B_00506460, E2B_00786970, E2B_00894613, E2B_00894617, E2B_00894629, E2B_00896465, E2B_00898784, E2B_00898796, E2B_00898918, E2B_00941125, E2B_00944258, E2B_00946463, E2B_00947254, E2B_00786948, E2B_00792724, E2B_01103249, E2B_01104135.

Organization: Health Canada

1365 page(s)
February 2024

Req # A-2020-000870

Adverse Drug Reactions (ADRs). Report numbers: E2B_01674763, E2B_02137119, 000723810, 000724215, 000724308, 000724654, 000724751, E2B_02429833, E2B_02438547, E2B_02304224, E2B_02304226, E2B_02359312.

Organization: Health Canada

98 page(s)
February 2024

Req # A-2020-001098

Adverse Drug Reactions (ADRs). Report numbers: E2B_02122343, E2B_02124829, E2B_02125454, E2B_02124823, E2B_02198090, E2B_02174028, E2B_02198927, E2B_02251024, E2B_02262610, E2B_02268152,E2B_02236011, E2B_02302657, E2B_02312268, E2B_02272665, E2B_02296322, E2B_02304916, E2B_02296326, E2B_02296362, E2B_02297747, E2B_02427141.

Organization: Health Canada

314 page(s)
February 2024

Req # A-2020-001185

Adverse Drug Reactions (ADRs). Report numbers: E2B_02432721, E2B_02432728, E2B_02432900, E2B_02432947, E2B_02433003, E2B_02433242, E2B_02433328, E2B_02433386, E2B_02434051, E2B_02434786, E2B_02435446, E2B_02435609, E2B_02435740, E2B_02436225, E2B_02436576, E2B_02436758, E2B_02437312, E2B_02437339, E2B_02437343.

Organization: Health Canada

260 page(s)
February 2024

Req # A-2020-001227

Adverse Drug Reactions (ADRs). Report numbers: E2B_02538249, E2B_02538715, E2B_02538723, E2B_02539929, E2B_02539930, E2B_02540245, E2B_02541195, E2B_02541203, E2B_02541612, E2B_02541907, E2B_02542078, E2B_02543068, E2B_02543070, E2B_02543071, E2B_02543073, E2B_02543087, E2B_02543655, E2B_02544120, E2B_02544258, E2B_02545002.

Organization: Health Canada

468 page(s)
February 2024
Date modified: